ESC 365 - Empagliflozin improves left ventricular diastolic function in db/db mice without altering cardiac expression of enzymes relevant for ketone body or branched chain amino acid catabolism.

ESC Premium Access

Empagliflozin improves left ventricular diastolic function in db/db mice without altering cardiac expression of enzymes relevant for ketone body or branched chain amino acid catabolism.

Session: Targeting reverse remodelling in heart failure

Topic: Pharmacotherapy

Speaker: Mrs J. Moellmann (Aachen, DE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Mrs Julia Moellmann

RWTH University Hospital Aachen, Aachen (Germany)

0 follower

6 more presentations in this session

Feasibility and efficacy of early donepezil with or without metoprolol in reperfused myocardial infarction rats

Speaker: Doctor M. Li (Osaka, JP)

The best of two worlds: Vascular protection and decongestion without RAAS stimulation mediated by a novel dual acting V1a/V2 vasopressin receptor antagonist

Speaker: Doctor P. Kolkhof (Wuppertal, DE)

Cardioprotective effects of a novel designer C-type natriuretic peptide-based therapeutic, C53 , for the prevention of post-myocardial infarction heart failure

Speaker: Mr Y. Chen (Rochester, US)

Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat

Speaker: Doctor H. Yip (Kaohsiung, TW)

Empagliflozin prevention of heart failure development in diabetes is associated with an improvement in cardiac energy producition

Speaker: Professor S. Verma (Toronto, CA)

Access the full session

Targeting reverse remodelling in heart failure

Speakers: Mrs J. Moellmann, Doctor M. Li, Doctor P. Kolkhof, Mr Y. Chen, Doctor H. Yip...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources